Skip to main content
Back
Watch Compare

Verrica Pharmaceuticals Inc.

Data quality: 100%
VRCA
Nasdaq Manufacturing Chemicals
$5.78
▼ $0.04 (-0.69%)
Mkt Cap: 99.29 M
Price
$5.78
Mkt Cap
99.29 M
Day Range
$5.57 — $5.91
52-Week Range
$3.28 — $9.82
Volume
16,052
Open $5.82
50D / 200D Avg
$5.92
2.35% below
50D / 200D Avg
$5.97
3.18% below

Quick Summary

Key Takeaways

Revenue grew 31.22% annually over 5 years — strong growth
Negative free cash flow of -17.63 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 339.00%
Capital efficient — spends only 0.00% of revenue on capex

Growth

Revenue Growth (5Y)
31.22%
Above sector avg (9.35%)
Revenue (1Y)370.22%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Quality

Return on Equity
N/A
ROIC-88.02%
Net Margin-50.27%
Op. Margin-34.25%

Safety

Debt / Equity
N/A
Current Ratio1.25
Interest Coverage-1.57

Valuation

PE (TTM)
-5.55
Below sector avg (-1.98)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Price History

Financial Trends

Peer Comparison

vs Manufacturing sector median (44 peers)
Metric Stock Sector Median
P/E -5.6 -2.0
P/B — 5.1
ROE % — -51.0
Net Margin % -50.3 -150.2
Rev Growth 5Y % 31.2 9.3
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) 370.22% Revenue Growth (3Y) 163.50%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 31.22% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 35.58 M Net Income (TTM) -17.89 M
ROE N/A ROA -44.71%
Gross Margin N/A Operating Margin -34.25%
Net Margin -50.27% Free Cash Flow (TTM) -17.63 M
ROIC -88.02% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 1.25
Interest Coverage -1.57 Asset Turnover 0.89
Working Capital 7.37 M Tangible Book Value -17.04 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -5.55 Forward P/E N/A
P/B Ratio N/A P/S Ratio 2.79
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -17.75%
Market Cap 99.29 M Enterprise Value 99.82 M
Per Share
EPS (Diluted TTM) -1.68 Revenue / Share 2.07
FCF / Share -1.03 OCF / Share -1.03
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 0.00% FCF Conversion 98.55%
SBC-Adj. FCF N/A Growth Momentum 339.00

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 35.58 M 7.57 M 5.12 M 9.03 M 12.00 M
Net Income -17.89 M -76.58 M -67.00 M -24.49 M -35.08 M
EPS (Diluted) -1.68 -1.48 -1.48 -0.72 —
Gross Profit — — — — —
Operating Income -12.19 M -65.92 M -65.76 M -21.30 M -30.91 M
EBITDA — — — — —
R&D Expenses 8.86 M 11.84 M 20.30 M 12.20 M 15.93 M
SG&A Expenses 35.22 M 58.82 M 47.31 M — —
D&A — — — — —
Interest Expense 7.74 M 9.41 M 3.96 M 2.17 M 4.30 M
Income Tax 0.0 0.0 0.0 — —

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 47.13 M 54.13 M 81.60 M 44.72 M 80.13 M
Total Liabilities 22.39 M 63.99 M 61.83 M 4.69 M 47.52 M
Shareholders' Equity 24.74 M -9.86 M 19.76 M 40.03 M 32.61 M
Total Debt 0.0 30.98 M 42.87 M 0.0 41.69 M
Cash & Equivalents 30.15 M 46.33 M 69.55 M 34.27 M 15.75 M
Current Assets 42.54 M 51.18 M 77.53 M 39.12 M 74.33 M
Current Liabilities 16.44 M 29.01 M 17.02 M 3.46 M 46.06 M